Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT05777551

AF Ablation With High Power Short Duration RF

Led by Clinica Mediterranea · Updated on 2024-03-05

850

Participants Needed

9

Research Sites

260 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multi-center, research study designed to evaluate the safety and efficacy of pulmonary vein (PV) isolation with high power short duration radiofrequency energy in patients with paroxysmal/persistent atrial fibrillation (AF). Subjects with paroxysmal/persistent AF will undergo catheter ablation using commercially approved devices (mapping system and catheters). Patients will be followed up for 12 months to measure the recurrence of AF and its predictors. The primary endpoint will be to investigate the association between clinical and procedural characteristics and the efficacy and the safety of PVI performed with HPSD. At least 850 consecutive will be enrolled to have an adequate statistical power for the analysis of the primary endpoint. We assume that the freedom form AF recurrence at 12 months will be 80%. Expected R\^2 (Cox-Snell) 0.1. Candidate variables to be included in the model:10. Shrinkage level: 0.9. Based on these assumption the minimum number of patients is 850 with 170 events and EPP 17.

CONDITIONS

Official Title

AF Ablation With High Power Short Duration RF

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with paroxysmal or persistent atrial fibrillation who have signed informed consent
  • Patients currently using oral anticoagulation medication
Not Eligible

You will not qualify if you...

  • Previous ablation treatment for atrial fibrillation
  • Left ventricular ejection fraction less than 35%
  • Women who may be pregnant
  • Contraindications to X-ray exposure
  • History of congenital heart disease or cardiac surgery within the past month

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

Centre Cardiologique Du Nord

Paris, France

Actively Recruiting

2

Clinica Montevergine

Mercogliano, AV, Italy

Actively Recruiting

3

Maria cecilia Hospital

Cotignola, RA, Italy

Actively Recruiting

4

Ospedale di Conegliano

Conegliano, TV, Italy

Actively Recruiting

5

Università Politecnica delle Marche

Ancona, Italy

Actively Recruiting

6

Ospedale Civile di Asti

Asti, Italy

Actively Recruiting

7

Clinica Mediterranea

Naples, Italy, 80100

Actively Recruiting

8

Città della Salute e della Scienza di Torino, Dipartimento di Scienze Mediche della Università di Torino.

Torino, Italy

Not Yet Recruiting

9

Royal Papworth Hospital

Cambridge, United Kingdom

Not Yet Recruiting

Loading map...

Research Team

G

Giuseppe Stabile, MD

CONTACT

T

Teresa Strisciuglio, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here